<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2017-06-23" updated="2019-12-02">
  <drugbank-id primary="true">DB13268</drugbank-id>
  <name>Acetarsol</name>
  <description>Acetarsol, with the molecular formula N-acetyl-4-hydroxy-m-arsanilic acid, is a pentavalent arsenical compound with antiprotozoal and antihelmintic properties.[L2622] It was first discovered in 1921 by Ernest Fourneau at the Pasteur Institute. It was developed by Neolab Inc, and approved by Health Canada as an antifungal on December 31, 1964. It has been canceled and withdrawn from the market since August 12, 1997.[L113]</description>
  <cas-number>97-44-9</cas-number>
  <unii>806529YU1N</unii>
  <average-mass>275.0903</average-mass>
  <monoisotopic-mass>274.977493852</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>withdrawn</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32839</ref-id>
        <pubmed-id>13199327</pubmed-id>
        <citation>PECK BJ: Exfoliative dermatitis after acetarsol vaginal pessaries. Br Med J. 1954 Oct 9;2(4892):850-1.</citation>
      </article>
      <article>
        <ref-id>A32841</ref-id>
        <pubmed-id>13374373</pubmed-id>
        <citation>WHITE A: Acute systemic reaction to acetarsol. Br Med J. 1956 Dec 29;2(5008):1528-9.</citation>
      </article>
      <article>
        <ref-id>A32846</ref-id>
        <pubmed-id>21577301</pubmed-id>
        <citation>Lawrance IC: Novel topical therapies for distal colitis. World J Gastrointest Pharmacol Ther. 2010 Oct 6;1(5):87-93. doi: 10.4292/wjgpt.v1.i5.87.</citation>
      </article>
      <article>
        <ref-id>A32868</ref-id>
        <pubmed-id>29457211</pubmed-id>
        <citation>Kiely CJ, Clark A, Bhattacharyya J, Moran GW, Lee JC, Parkes M: Acetarsol Suppositories: Effective Treatment for Refractory Proctitis in a Cohort of Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2018 Apr;63(4):1011-1015. doi: 10.1007/s10620-017-4890-6. Epub 2018 Feb 19.</citation>
      </article>
    </articles>
    <textbooks>
      <textbook>
        <ref-id>T187</ref-id>
        <isbn>81-7648-125-4</isbn>
        <citation>Nath R. (2000). Health and disease role of micronutrients and trace elements. New Apcon.</citation>
      </textbook>
      <textbook>
        <ref-id>T189</ref-id>
        <isbn>0-398-05860-1</isbn>
        <citation>Morton W. and Schuman J. (1993). Toxicology of the eye (4th ed.). Charles C Thomas.</citation>
      </textbook>
    </textbooks>
    <links>
      <link>
        <ref-id>L1113</ref-id>
        <title>Health Canada</title>
        <url>https://health-products.canada.ca/dpd-bdpp/dispatch-repartition.do</url>
      </link>
      <link>
        <ref-id>L2622</ref-id>
        <title>National Cancer Institute</title>
        <url>https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&amp;ns=NCI_Thesaurus&amp;code=C61621</url>
      </link>
      <link>
        <ref-id>L2624</ref-id>
        <title>NIH</title>
        <url>https://drugs.ncats.io/ginas/app/substance/e7e0485f</url>
      </link>
      <link>
        <ref-id>L2626</ref-id>
        <title>NHS</title>
        <url>https://www.sps.nhs.uk/wp-content/uploads/2015/06/QA17.7_Can_actarsol_be_used_to_treat_proctitis-Final.docx</url>
      </link>
      <link>
        <ref-id>L2627</ref-id>
        <title>NIH</title>
        <url>https://meshb.nlm.nih.gov/record/ui?name=Protozoan%20Infections</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>Acetarsol has been used for the treatment of different diseases such as syphilis, amoebiasis, yaws, trypanosomiasis, and malaria.[L2624] Acetarsol was used commonly for the treatment of vaginitis due to _Trichomonas vaginalis_ and _Candida albicans_.[A32839, A32841] When orally administered, acetarsol can be used for the treatment of intestinal amoebiasis and in the form of suppositories it has been researched for the treatment of proctitis.[L2626]&#13;
&#13;
Protozoan infections are parasitic diseases characterized to be caused by organisms classified in the kingdom Protozoa which is formed by a great diversity of organisms.[L2627]</indication>
  <pharmacodynamics>Some reports indicate a certain infection remission with the use of acetarsol but this reports also demonstrate the absorption of systemic arsenic which can be physiologically dangerous.[A32846]</pharmacodynamics>
  <mechanism-of-action>The mechanism of action of acetarsol is not well known but it is thought to bind to protein-containing sulfhydryl groups located in the infective microorganism and to form a lethal As-S bond. The formation of this bond impairs the protein to function and it eventually kills the microorganism.[L2622]</mechanism-of-action>
  <toxicity>The administration of inorganic arsenic is highly carcinogenic and thus acetarsol if thought to be dangerous when absorbed.[A32868] Some reports indicate that acetarsol can produce effects in the eyes such as optic neuritis and optic atrophy.[T189]</toxicity>
  <metabolism>This pharmacokinetic property was not addressed.</metabolism>
  <absorption>The absorption seems to be very minimal but there are reports of allergic reactions after vaginal administration of acetarsol.[A32839]</absorption>
  <half-life>This pharmacokinetic property was not addressed.</half-life>
  <protein-binding>This pharmacokinetic property was not addressed.</protein-binding>
  <route-of-elimination>The arsenic found in acetarsol is excreted mainly in the urine.[T187] The level of arsenic after acetarsol administration almost reaches the toxic range in urine.[A32868]</route-of-elimination>
  <volume-of-distribution>This pharmacokinetic property was not addressed.</volume-of-distribution>
  <clearance>This pharmacokinetic property was not addressed.</clearance>
  <classification>
    <description>This compound belongs to the class of organic compounds known as acetanilides. These are organic compounds containing an acetamide group conjugated to a phenyl group.</description>
    <direct-parent>Acetanilides</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Benzenoids</superclass>
    <class>Benzene and substituted derivatives</class>
    <subclass>Anilides</subclass>
    <alternative-parent>1-hydroxy-2-unsubstituted benzenoids</alternative-parent>
    <alternative-parent>Acetamides</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>N-acetylarylamines</alternative-parent>
    <alternative-parent>Organic metalloid salts</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Oxygen-containing organoarsenic compounds</alternative-parent>
    <alternative-parent>Pentaorganoarsanes</alternative-parent>
    <alternative-parent>Secondary carboxylic acid amides</alternative-parent>
    <substituent>1-hydroxy-2-unsubstituted benzenoid</substituent>
    <substituent>Acetamide</substituent>
    <substituent>Acetanilide</substituent>
    <substituent>Aromatic homomonocyclic compound</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxamide group</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>N-acetylarylamine</substituent>
    <substituent>N-arylamide</substituent>
    <substituent>Organic metalloid salt</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organic salt</substituent>
    <substituent>Organoarsenic compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Oxygen-containing organoarsenic compound</substituent>
    <substituent>Pentaorganoarsane</substituent>
    <substituent>Phenol</substituent>
    <substituent>Secondary carboxylic acid amide</substituent>
  </classification>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Neo Vagex</name>
      <labeller>Neolab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00147591</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1964-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Vaginal</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Neo Vagex</name>
      <ingredients>Acetarsol + Benzalkonium + Clioquinol</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Agents Against Leishmaniasis and Trypanosomiasis</category>
      <mesh-id/>
    </category>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Anti-Infective Agents</category>
      <mesh-id>D000890</mesh-id>
    </category>
    <category>
      <category>Antidiarrheals, Intestinal Antiinflammatory/antiinfective Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antiparasitic Products, Insecticides and Repellents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antiprotozoals</category>
      <mesh-id>D000981</mesh-id>
    </category>
    <category>
      <category>Arsenicals</category>
      <mesh-id>D001152</mesh-id>
    </category>
    <category>
      <category>Drugs that are Mainly Renally Excreted</category>
      <mesh-id/>
    </category>
    <category>
      <category>Genito Urinary System and Sex Hormones</category>
      <mesh-id/>
    </category>
    <category>
      <category>Gynecological Antiinfectives and Antiseptics</category>
      <mesh-id/>
    </category>
    <category>
      <category>Intestinal Antiinfectives</category>
      <mesh-id/>
    </category>
    <category>
      <category>Organometallic Compounds</category>
      <mesh-id>D009942</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
    <affected-organism>Trichomonas vaginalis, Giardia duodenalis, and Entamoeba histolytica</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Tablet</form>
      <route>Vaginal</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="G01AB01">
      <level code="G01AB">Arsenic compounds</level>
      <level code="G01A">ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS</level>
      <level code="G01">GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS</level>
      <level code="G">GENITO URINARY SYSTEM AND SEX HORMONES</level>
    </atc-code>
    <atc-code code="P01CD02">
      <level code="P01CD">Arsenic compounds</level>
      <level code="P01C">AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS</level>
      <level code="P01">ANTIPROTOZOALS</level>
      <level code="P">ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS</level>
    </atc-code>
    <atc-code code="A07AX02">
      <level code="A07AX">Other intestinal antiinfectives</level>
      <level code="A07A">INTESTINAL ANTIINFECTIVES</level>
      <level code="A07">ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB13268.pdf?1525211848</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.15</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-2</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.80e+00 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-0.031</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(3-acetamido-4-hydroxyphenyl)arsonic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>amoebal</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>275.0903</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>274.977493852</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CC(=O)NC1=CC(=CC=C1O)[As](O)(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C8H10AsNO5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C8H10AsNO5/c1-5(11)10-7-4-6(9(13,14)15)2-3-8(7)12/h2-4,12H,1H3,(H,10,11)(H2,13,14,15)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>ODFJOVXVLFUVNQ-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>106.86</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>48.89</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>21.45</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>3.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-4.5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Slightly soluble </value>
      <source>Schnitzer J. and Hawking F.  1963. Experimental chemotherapy.</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>225-227 ÂºC</value>
      <source>'MSDS'</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>9878</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>135135</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>1908</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Acetarsol</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1330792</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>